For most medical device production, a risk-based quality control approach is the right choice. Regulatory frameworks like ISO 13485 and the EU Medical Device Regulation (MDR) are built around risk management principles, meaning they require manufacturers to apply quality control effort proportional to the hazard a device poses rather than following a fixed, one-size-fits-all checklist. That said, prescriptive elements still have a place in certain production contexts, and understanding when to use each approach makes a real difference to both compliance and efficiency. This article walks through the key differences, what regulations actually demand, and how to make the right call for your specific product.
What are the core differences between risk-based and prescriptive quality control?
The core difference is that risk-based quality control allocates inspection and testing resources according to identified hazards and their likelihood of occurring, while prescriptive quality control follows a fixed set of rules, checkpoints, or procedures regardless of the actual risk profile of the product or process. Risk-based QC is flexible and evidence-driven; prescriptive QC is uniform and rule-driven.
In a prescriptive model, every batch goes through the same checks in the same sequence with the same acceptance criteria. There is no adjustment based on the criticality of a component or the historical performance of a supplier. This approach is straightforward to implement and easy to audit, but it can result in over-inspecting low-risk elements while under-resourcing genuinely critical ones.
Risk-based quality control, by contrast, begins with a structured risk assessment. Teams identify what could go wrong, evaluate the severity and probability of each failure mode, and then design quality control activities around those findings. Higher-risk steps in the production process receive more intensive scrutiny, while lower-risk steps may be managed with lighter controls. This is not about doing less work overall; it is about doing the right work in the right places.
In medical device manufacturing, the distinction matters enormously. A disinfectant wet wipe used in a hospital environment, for example, carries very different risk implications than a consumer cosmetic wipe. The quality control methods applied to each should reflect those differences in consequence.
Which quality control approach does medical device regulation actually require?
Medical device regulation requires a risk-based approach to quality control. Both ISO 13485 and the EU MDR are explicitly structured around risk management principles. ISO 13485, the international quality management standard for medical device manufacturers, requires organizations to apply a risk-based approach throughout the product lifecycle, from design and development through to post-market surveillance. The MDR reinforces this by requiring manufacturers to maintain a comprehensive risk management file aligned with ISO 14971.
ISO 14971 is the dedicated standard for risk management in medical devices. It requires manufacturers to identify hazards, estimate and evaluate associated risks, control those risks, and monitor the effectiveness of those controls. This framework feeds directly into how quality control is designed and implemented on the production floor.
Prescriptive elements do appear within these regulatory frameworks, but they exist as minimum requirements rather than complete quality systems. For example, certain documentation must always be present, and specific tests are mandatory for particular device classifications. These fixed requirements sit inside a broader risk-based structure rather than replacing it.
At Teampac, our processes from product development through to manufacturing are covered by the ISO 13485 quality management system, and we are fully familiar with what MDR compliance means in practice. If you are looking for a healthcare product manufacturing partner who understands these regulatory requirements from the ground up, we are ready to support you.
When does a prescriptive QC approach still make sense in medical device production?
A prescriptive quality control approach still makes sense in medical device production when the process involves well-understood, highly standardized steps where the risk profile is stable and consistently low, or where regulatory requirements mandate specific fixed procedures. Prescriptive controls also work well as a baseline layer within a broader risk-based system.
There are several scenarios where prescriptive elements remain valuable:
- Mandatory regulatory tests: Certain device classifications require specific tests by regulation, regardless of risk assessment outcomes. These cannot be substituted with risk-based alternatives.
- High-volume commodity components: For standardized inputs with long, stable supplier histories, a fixed inspection protocol can be efficient and sufficient.
- Early-stage production: When a new product or process lacks sufficient data to build a reliable risk model, starting with prescriptive controls provides a safe foundation while data is gathered.
- Training and onboarding: Prescriptive procedures are easier to communicate and follow consistently for new team members before they develop deeper process understanding.
The key insight is that prescriptive and risk-based approaches are not mutually exclusive. The most effective quality management systems in medical device production use prescriptive controls where they are mandated or clearly efficient, and risk-based controls everywhere else. The balance shifts depending on the product, the production environment, and the maturity of the quality system.
How does risk-based quality control work in practice on a production line?
On a production line, risk-based quality control works by first mapping the process to identify where failures could occur, then assigning control measures and inspection intensity based on the severity and likelihood of those failures. In practice, this means different steps in the same production run may receive very different levels of scrutiny depending on their risk contribution.
The practical implementation typically follows a structured sequence:
- Hazard identification: The production process is mapped step by step, and potential failure modes are identified at each stage. For liquid-based products like disinfectant wipes or wound cleansing solutions, this includes raw material contamination, formula concentration errors, and packaging integrity failures.
- Risk estimation: Each identified hazard is assessed for severity of harm and probability of occurrence. Some manufacturers also factor in detectability, which influences how likely a failure is to reach the end user undetected.
- Control assignment: Quality control measures are assigned based on risk level. High-risk steps may require 100% inspection, in-process testing, or additional validation steps. Lower-risk steps may be covered by statistical sampling or periodic audits.
- Monitoring and review: Risk assessments are not static. Production data, non-conformance reports, and supplier performance feed back into the risk model, triggering control updates when the risk profile changes.
This approach keeps quality control responsive to reality rather than locked into procedures that may no longer reflect the actual hazard landscape. It also supports efficient use of resources, which is particularly relevant in outsourced production where time and cost management directly affect the value of the partnership.
What are the advantages and disadvantages of each approach for outsourced production?
For outsourced medical device production, risk-based quality control offers greater flexibility and efficiency, while prescriptive quality control offers simplicity and auditability. The right balance depends on the complexity of the product, the maturity of the contract manufacturer’s quality system, and the level of oversight the brand owner wants to maintain.
Risk-based quality control in outsourced production
The main advantages of a risk-based approach for outsourced production include the ability to scale control intensity with product complexity, more efficient use of testing and inspection resources, and a quality system that adapts as production data accumulates. For brand owners, this means their contract manufacturer is focusing effort where it genuinely matters rather than applying uniform checks that may not reflect actual product risk.
The disadvantage is that risk-based systems require a higher level of expertise to design and maintain. A contract manufacturer needs experienced quality professionals who understand both the regulatory framework and the specific hazard profile of the products they manufacture. Without that expertise, a risk-based system can become inconsistent or difficult to defend in an audit.
Prescriptive quality control in outsourced production
Prescriptive controls are easier to specify in a contract, easier to verify during supplier audits, and easier to communicate to production staff. For brand owners who want clear, fixed deliverables from their manufacturing partner, prescriptive QC requirements are straightforward to write into a quality agreement.
The downside is inflexibility. Prescriptive systems do not adapt well to changes in product formulation, new raw material sources, or shifts in production volume. They can also create inefficiency by applying the same level of scrutiny to low-risk and high-risk elements alike, which adds cost without adding proportionate safety benefit.
How should you choose between risk-based and prescriptive QC for your product?
Choose risk-based quality control as your primary framework if your product is a medical device or falls under MDR or biocidal product regulations, if your production involves complex formulations or multiple critical process steps, or if you are working with a contract manufacturer who has a mature ISO 13485-certified quality system. Choose prescriptive controls as a supplementary layer for mandatory regulatory requirements and highly standardized process steps.
A practical decision framework looks like this:
- Is the product classified as a medical device? If yes, risk-based QC aligned with ISO 14971 is a regulatory requirement, not an option.
- How complex is the formulation and production process? Greater complexity increases the value of a risk-based approach because the hazard landscape is more varied.
- How mature is your quality system or that of your contract manufacturer? Risk-based systems require data and expertise to function well. If either is lacking, start with more prescriptive controls and evolve toward risk-based as knowledge builds.
- What do your customers and regulators expect? Healthcare customers and regulatory bodies increasingly expect risk-based thinking to be visible in your quality documentation.
- Are there fixed regulatory tests for your device class? These must be included regardless of your overall QC philosophy.
For most medical device and healthcare product manufacturers, the answer is not a binary choice. A well-designed quality management system uses risk-based thinking as its foundation and incorporates prescriptive requirements where regulation or process stability demands them. The goal is a system that is both defensible in an audit and genuinely effective at protecting product quality and patient safety.
If you are evaluating outsourced production options for healthcare or medical device products, we would be glad to walk you through how our quality processes work in practice. Contact us and one of our experts will get back to you. You can also explore our healthcare product manufacturing services to see the full range of products and support we offer.